Cleared Traditional

K241491 - Blueprint Patient-Specific Instrumentation

Also marketed or referenced as:
Shoulder iD Primary Reversed Glenoid

K241491 is an FDA 510(k) clearance for Blueprint Patient-Specific Instrumentation, manufactured by Stryker Corporation (Tornier, S.A.S.). The device is a Class 2 Orthopedic device with product code PHX cleared through the Traditional 510(k) pathway after a 139-day FDA review.

K241491 · Stryker Corporation (Tornier, S.A.S.) · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2024
Decision
139d
Days
Class 2
Risk

K241491 is an FDA 510(k) clearance for the Blueprint Patient-Specific Instrumentation. Classified as Shoulder Prosthesis, Reverse Configuration (product code PHX), Class II - Special Controls.

Submitted by Stryker Corporation (Tornier, S.A.S.) (Montbonnot-Saint-Martin, FR). The FDA issued a Cleared decision on October 10, 2024 after a review of 139 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3660 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Stryker Corporation (Tornier, S.A.S.) devices

FDA 510(k) Submission Details - K241491

510(k) Number K241491 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 24, 2024
Decision Date October 10, 2024
Days to Decision 139 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
17d slower than avg
Panel avg: 122d · This submission: 139d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

PHX Device Classification - Class 2, Special Controls

Product Code PHX Shoulder Prosthesis, Reverse Configuration
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3660
Definition Intended To Be Used To Relieve Pain And To Replace The Glenoid And Humeral Side Of The Shoulder Joint In Order To Restore Mobility In A Grossly Rotator Cuff Deficient Joint With Severe Arthropathy Or A Previous Joint Replacement With A Grossly Rotator Cuff Deficient Joint.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - PHX Shoulder Prosthesis, Reverse Configuration

All 183
Devices cleared under the same product code (PHX) and FDA review panel - the closest regulatory comparables to K241491.
restor3d Reverse Total Shoulder Arthroplasty System
K243643 · Restor3d · May 2025
AltiVate Reverse Shoulder System
K251184 · Encore Medical, L.P. · May 2025
JARVIS Glenoid Reverse Shoulder Prosthesis
K242253 · FH Industrie · Nov 2024
Equinoxe® Central Screw Baseplate System
K233482 · Exactech, Inc. · Jul 2024
AltiVate Reverse® Glenoid
K233481 · Encore Medical, L.P. · May 2024
Full Wedge Lateralized and Augmented Baseplates
K240278 · Fx Shoulder USA, Inc. · May 2024